Evidence map›Paper›PMID 37983675›Full record

ArticleAdvanced healthcare materials2024

Hybrid Endometrial-Derived Hydrogels: Human Organoid Culture Models and In Vivo Perspectives.

María Gómez-Álvarez, Clara Bueno-Fernandez, Adolfo Rodríguez-Eguren, Emilio Francés-Herrero, Marcos Agustina-Hernández, Amparo Faus, Fernando Gisbert Roca, Cristina Martínez-Ramos, Amparo Galán, Antonio Pellicer and 2 more

Abstract read
In one paragraph

Article in Advanced healthcare materials, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Organoid scaffold materials: research and application.Frontiers in bioengineering and biotechnology · 2025
    Review
  15. Review
  16. Article
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

María Gómez-ÁlvarezIVIRMA Global Research Alliance, IVI Foundation, Instituto de Investigación Sanitaria La Fe (IIS La Fe), Valencia, 46026, Spain.ORCID 0009-0007-1862-5403
Clara Bueno-FernandezIVIRMA Global Research Alliance, IVI Foundation, Instituto de Investigación Sanitaria La Fe (IIS La Fe), Valencia, 46026, Spain.ORCID 0000-0003-2093-6239
Adolfo Rodríguez-EgurenIVIRMA Global Research Alliance, IVI Foundation, Instituto de Investigación Sanitaria La Fe (IIS La Fe), Valencia, 46026, Spain.ORCID 0000-0002-1266-8513
Emilio Francés-HerreroIVIRMA Global Research Alliance, IVI Foundation, Instituto de Investigación Sanitaria La Fe (IIS La Fe), Valencia, 46026, Spain.ORCID 0000-0002-5202-8967
Marcos Agustina-HernándezIVIRMA Global Research Alliance, IVI Foundation, Instituto de Investigación Sanitaria La Fe (IIS La Fe), Valencia, 46026, Spain.ORCID 0000-0003-1025-8024
Amparo FausIVIRMA Global Research Alliance, IVI Foundation, Instituto de Investigación Sanitaria La Fe (IIS La Fe), Valencia, 46026, Spain.
Fernando Gisbert RocaUniversitat Politècnica de València, Centre for Biomaterials and Tissue Engineering, Valencia, 46022, Spain.
Cristina Martínez-RamosUniversitat Politècnica de València, Centre for Biomaterials and Tissue Engineering, Valencia, 46022, Spain.
Amparo GalánLaboratory of Neuroendocrinology, Prince Felipe Research Center (CIPF), Valencia, 46012, Spain.
Antonio PellicerIVIRMA Global Research Alliance, IVIRMA, Rome, Roma, 00197, Italy.
Hortensia FerreroIVIRMA Global Research Alliance, IVI Foundation, Instituto de Investigación Sanitaria La Fe (IIS La Fe), Valencia, 46026, Spain.
Irene CervellóIVIRMA Global Research Alliance, IVI Foundation, Instituto de Investigación Sanitaria La Fe (IIS La Fe), Valencia, 46026, Spain.ORCID 0000-0002-7018-4971

Funding

Conselleria de Cultura, Educación y Ciencia, Generalitat Valenciana CIAPOT/2022/29Conselleria de Cultura, Educación y Ciencia, Generalitat Valenciana CIPROM/2021/058Fondo Social Europeo PI21/00305Instituto de Salud Carlos III and co-founded by the European Union (Fondo Social Europeo), «El FSE invierte en tu futuro» CP19/00149Instituto de Salud Carlos III and co-founded by the European Union (Fondo Social Europeo), «El FSE invierte en tu futuro» CP20/00120Instituto de Salud Carlos III and co-founded by the European Union (Fondo Social Europeo), «El FSE invierte en tu futuro» PI21/00305Ministerio de Universidades FPU18/06327Ministerio de Universidades FPU19/04850Ministerio de Universidades FPU20/00251Ministerio de Universidades MS21-142Universitat Politècnica de València PAID-10-22
6 · The paper itself

Abstract

The endometrium plays a vital role in fertility, providing a receptive environment for embryo implantation and development. Understanding the endometrial physiology is essential for developing new strategies to improve reproductive healthcare. Human endometrial organoids (hEOs) are emerging as powerful models for translational research and personalized medicine. However, most hEOs are cultured in a 3D microenvironment that significantly differs from the human endometrium, limiting their applicability in bioengineering. This study presents a hybrid endometrial-derived hydrogel that combines the rigidity of PuraMatrix (PM) with the natural scaffold components and interactions of a porcine decellularized endometrial extracellular matrix (EndoECM) hydrogel. This hydrogel provides outstanding support for hEO culture, enhances hEO differentiation efficiency due to its biochemical similarity with the native tissue, exhibits superior in vivo stability, and demonstrates xenogeneic biocompatibility in mice over a 2-week period. Taken together, these attributes position this hybrid endometrial-derived hydrogel as a promising biomaterial for regenerative treatments in reproductive medicine.

Indexed as

EndometriumHydrogelsOrganoidsAnimalsBiocompatible MaterialsCell DifferentiationDecellularized Extracellular MatrixExtracellular MatrixFemaleHumansMiceSwineTissue EngineeringTissue ScaffoldsBiocompatible MaterialsDecellularized Extracellular MatrixHydrogelsbioengineeringendometriumextracellular matrix hydrogelorganoids

Identifiers

PMID37983675
PMCPMC11468130

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.